Cite
Gene- and variant-specific efficacy of serum/glucocorticoid-regulated kinase 1 inhibition in long QT syndrome types 1 and 2
MLA
Giannetti, Federica, et al. Gene- and Variant-Specific Efficacy of Serum/Glucocorticoid-Regulated Kinase 1 Inhibition in Long QT Syndrome Types 1 and 2. May 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1c04ac7456d2158420e5c7310d0aca50&authtype=sso&custid=ns315887.
APA
Giannetti, F., Barbieri, M., Shiti, A., Casini, S., Sager, P. T., Das, S., Pradhananga, S., Srinivasan, D., Nimani, S., Alerni, N., Louradour, J., Mura, M., Gnecchi, M., Brink, P., Zehender, M., Koren, G., Zaza, A., Crotti, L., Wilde, A. A. M., … Odening, K. E. (2023). Gene- and variant-specific efficacy of serum/glucocorticoid-regulated kinase 1 inhibition in long QT syndrome types 1 and 2.
Chicago
Giannetti, Federica, Miriam Barbieri, Assad Shiti, Simona Casini, Philip T Sager, Saumya Das, Sabindra Pradhananga, et al. 2023. “Gene- and Variant-Specific Efficacy of Serum/Glucocorticoid-Regulated Kinase 1 Inhibition in Long QT Syndrome Types 1 and 2,” May. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1c04ac7456d2158420e5c7310d0aca50&authtype=sso&custid=ns315887.